Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function.

Authors:
Ramil CP; Xiang H; Zhang P; Cronin A; Cabral L and 8 more

Journal:
Oncoimmunology

Publication Year: 2024

DOI:
10.1080/2162402X.2023.2300882

PMCID:
PMC10773711

PMID:
38192443

Journal Information

Full Title: Oncoimmunology

Abbreviation: Oncoimmunology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the mass spectrometry proteomics data have been deposited to the proteomexchange consortium via the pride partner repository with the dataset identifiers pxd035259 and pxd035248."

Code Sharing
Evidence found in paper:

"Disclosure statement All authors are current or previous employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and shareholders of Merck & Co., Inc., Rahway, NJ, USA."

Evidence found in paper:

"This work was supported by the Merck & Co., Inc., Rahway, NJ, USA Research Laboratories Postdoctoral Research Program."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025